SNY Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$54.61median target· current $43.08 (+26.8%)10 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
47 articles · sorted by datePage 1 of 3 · 47 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio23.04Forward 8.69
EPS (TTM)$1.87-91.2% YoY
Profit margin8.1%HEALTHCARE
Market cap$103.23BLarge cap
Valuation
- Forward P/E
- 8.69
- PEG ratio
- 3.78
- P/B
- 1.30
- P/S (TTM)
- 2.11
- EV/EBITDA
- 8.22
Profitability & growth
- ROE (TTM)
- 5.7%
- Operating margin
- 21.0%
- Revenue growth YoY
- 14.6%
- Dividend yield
- 9.6%
- Beta
- 0.28
Last earnings
Jul 30, 2026 · Estimate $1.10 · Reported $1.21
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Sanofi ADR
Company profileSanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Classification
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 46, AVENUE DE LA GRANDE ARMEE, PARIS
- Fiscal year end
- December
- Latest quarter
- Jun 30, 2026
Market cap$103.23B
Shares outstanding$2.40B
52W high$49.91
52W low$40.89
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent